Evidence map›Paper›PMID 27833376›Full record

ArticleWorld journal of gastroenterology2016

Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.

Hee Chul Nam, Bohyun Jang, Myeong Jun Song

Open access · hybridAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. [Treatment and prevention of bile duct injury in hepatocellular carcinoma after transarterial chemoembolization].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hee Chul NamHee Chul Nam, Bohyun Jang, Myeong Jun Song, Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul 06591, South Korea.
Bohyun JangHee Chul Nam, Bohyun Jang, Myeong Jun Song, Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul 06591, South Korea.
Myeong Jun SongHee Chul Nam, Bohyun Jang, Myeong Jun Song, Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul 06591, South Korea.
Catholic University of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transarterial chemoembolization (TACE) is a widely used standard treatment for patients with hepatocellular carcinoma (HCC) who are not suitable candidates for curative treatments. The rationale for TACE is that intra-arterial chemotherapy using lipiodol and chemotherapeutic agents, followed by selective vascular embolization, results in a strong cytotoxic effect as well as ischemia (conventional TACE). Recently, drug-eluting beads (DC Beads

Indexed as

Chemoembolization, TherapeuticAntibiotics, AntineoplasticCarcinoma, HepatocellularCost-Benefit AnalysisDoxorubicinHumansLiver NeoplasmsOutcome Assessment, Health CareAntibiotics, AntineoplasticDoxorubicinConventional TACEDrug-eluting beadsHepatocellular carcinomaTransarterial chemoembolizationTreatment response

Identifiers

PMID27833376
PMCPMC5083790
OpenAlexW2541214016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.